APO Research
Talk to an analyst

APO RESEARCH · REPORT

Point-of-Care Testing (POCT)

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Selected research

Market Analysis & Forecast

Global Point-of-Care Testing (POCT) Market Analysis and Forecast 2026-2032

21 December 2025211 pages

Choose your research edition.

Industry ResearchPoint-of-Care Testing (POCT) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Point-of-Care Testing (POCT) Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Point-of-Care Testing (POCT) Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Point-of-Care Testing (POCT) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

This report presents an overview of global market for Point-of-Care Testing (POCT), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Point-of-Care Testing (POCT), also provides the sales of main regions and countries. Of the upcoming market potential for Point-of-Care Testing (POCT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Point-of-Care Testing (POCT) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Point-of-Care Testing (POCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Point-of-Care Testing (POCT) sales, projected growth trends, production technology, application and end-user industry.

Point-of-Care Testing (POCT) Segment by Company

Roche

Abbott

Johnson & Johnson

Siemens Healthcare

Danaher

Ascensia

Bio-Rad Laboratories

BioMerieux

ARKRAY

Nova Biomedical

Trividia Health

Quidel

Accriva

OraSure Technologies

Helena Laboratories

A. Menarini Diagnostics

Abaxis (Zoetis)

Ortho Clinical Diagnostics

Phamatech

Chembio Diagnostics

Trinity Biotech

ELITech Group

Response Biomedical

Princeton BioMeditech

Alfa Wassermann

Point-of-Care Testing (POCT) Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Point-of-Care Testing (POCT) Segment by Application

Clinics

Hospitals

Laboratory

Others

Point-of-Care Testing (POCT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Point-of-Care Testing (POCT) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point-of-Care Testing (POCT) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Point-of-Care Testing (POCT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Glucose Testing Major Manufacturers Table 3. Infectious Diseases Testing Major Manufacturers Table 4. Cardiac Markers Testing Major Manufacturers Table 5. Coagulation Testing Major Manufacturers Table 6. Pregnancy and Fertility Testing Major Manufacturers Table 7. Blood Gas/Electrolytes Testing Major Manufacturers Table 8. Urinalysis Testing Major Manufacturers Table 9. Global Point-of-Care Testing (POCT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Clinics Major Manufacturers Table 11. Hospitals Major Manufacturers Table 12. Laboratory Major Manufacturers Table 13. Others Major Manufacturers Table 14. Point-of-Care Testing (POCT) Industry Trends Table 15. Point-of-Care Testing (POCT) Industry Drivers Table 16. Point-of-Care Testing (POCT) Industry Opportunities and Challenges Table 17. Point-of-Care Testing (POCT) Industry Restraints Table 18. Global Point-of-Care Testing (POCT) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Point-of-Care Testing (POCT) Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Point-of-Care Testing (POCT) Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2021-2026) Table 22. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2027-2032) Table 23. Global Point-of-Care Testing (POCT) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 24. Global Point-of-Care Testing (POCT) Sales by Region (2021-2026) & (M Units) Table 25. Global Point-of-Care Testing (POCT) Sales by Region (2027-2032) & (M Units) Table 26. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2021-2026) Table 27. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2027-2032) Table 28. Global Point-of-Care Testing (POCT) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Point-of-Care Testing (POCT) Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2021-2026) Table 32. Global Point-of-Care Testing (POCT) Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 33. Global Point-of-Care Testing (POCT) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application Table 36. Global Point-of-Care Testing (POCT) Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Point-of-Care Testing (POCT) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Point-of-Care Testing (POCT) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2026) Table 43. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2027-2032) Table 44. Global Point-of-Care Testing (POCT) Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 45. Global Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 46. Global Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 47. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2026) Table 48. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2027-2032) Table 49. Global Point-of-Care Testing (POCT) Price by Type (2021-2026) & (USD/Unit) Table 50. Global Point-of-Care Testing (POCT) Price by Type (2027-2032) & (USD/Unit) Table 51. Global Point-of-Care Testing (POCT) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2026) Table 55. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2027-2032) Table 56. Global Point-of-Care Testing (POCT) Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 57. Global Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 58. Global Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 59. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2026) Table 60. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2027-2032) Table 61. Global Point-of-Care Testing (POCT) Price by Application (2021-2026) & (USD/Unit) Table 62. Global Point-of-Care Testing (POCT) Price by Application (2027-2032) & (USD/Unit) Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Roche Point-of-Care Testing (POCT) Product Portfolio Table 67. Roche Recent Development Table 68. Abbott Company Information Table 69. Abbott Business Overview Table 70. Abbott Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Abbott Point-of-Care Testing (POCT) Product Portfolio Table 72. Abbott Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Siemens Healthcare Company Information Table 79. Siemens Healthcare Business Overview Table 80. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio Table 82. Siemens Healthcare Recent Development Table 83. Danaher Company Information Table 84. Danaher Business Overview Table 85. Danaher Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Danaher Point-of-Care Testing (POCT) Product Portfolio Table 87. Danaher Recent Development Table 88. Ascensia Company Information Table 89. Ascensia Business Overview Table 90. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Ascensia Point-of-Care Testing (POCT) Product Portfolio Table 92. Ascensia Recent Development Table 93. Bio-Rad Laboratories Company Information Table 94. Bio-Rad Laboratories Business Overview Table 95. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 97. Bio-Rad Laboratories Recent Development Table 98. BioMerieux Company Information Table 99. BioMerieux Business Overview Table 100. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. BioMerieux Point-of-Care Testing (POCT) Product Portfolio Table 102. BioMerieux Recent Development Table 103. ARKRAY Company Information Table 104. ARKRAY Business Overview Table 105. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. ARKRAY Point-of-Care Testing (POCT) Product Portfolio Table 107. ARKRAY Recent Development Table 108. Nova Biomedical Company Information Table 109. Nova Biomedical Business Overview Table 110. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 112. Nova Biomedical Recent Development Table 113. Trividia Health Company Information Table 114. Trividia Health Business Overview Table 115. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Trividia Health Point-of-Care Testing (POCT) Product Portfolio Table 117. Trividia Health Recent Development Table 118. Quidel Company Information Table 119. Quidel Business Overview Table 120. Quidel Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Quidel Point-of-Care Testing (POCT) Product Portfolio Table 122. Quidel Recent Development Table 123. Accriva Company Information Table 124. Accriva Business Overview Table 125. Accriva Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Accriva Point-of-Care Testing (POCT) Product Portfolio Table 127. Accriva Recent Development Table 128. OraSure Technologies Company Information Table 129. OraSure Technologies Business Overview Table 130. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio Table 132. OraSure Technologies Recent Development Table 133. Helena Laboratories Company Information Table 134. Helena Laboratories Business Overview Table 135. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 137. Helena Laboratories Recent Development Table 138. A. Menarini Diagnostics Company Information Table 139. A. Menarini Diagnostics Business Overview Table 140. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 142. A. Menarini Diagnostics Recent Development Table 143. Abaxis (Zoetis) Company Information Table 144. Abaxis (Zoetis) Business Overview Table 145. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio Table 147. Abaxis (Zoetis) Recent Development Table 148. Ortho Clinical Diagnostics Company Information Table 149. Ortho Clinical Diagnostics Business Overview Table 150. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 151. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 152. Ortho Clinical Diagnostics Recent Development Table 153. Phamatech Company Information Table 154. Phamatech Business Overview Table 155. Phamatech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 156. Phamatech Point-of-Care Testing (POCT) Product Portfolio Table 157. Phamatech Recent Development Table 158. Chembio Diagnostics Company Information Table 159. Chembio Diagnostics Business Overview Table 160. Chembio Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 161. Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 162. Chembio Diagnostics Recent Development Table 163. Trinity Biotech Company Information Table 164. Trinity Biotech Business Overview Table 165. Trinity Biotech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 166. Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio Table 167. Trinity Biotech Recent Development Table 168. ELITech Group Company Information Table 169. ELITech Group Business Overview Table 170. ELITech Group Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 171. ELITech Group Point-of-Care Testing (POCT) Product Portfolio Table 172. ELITech Group Recent Development Table 173. Response Biomedical Company Information Table 174. Response Biomedical Business Overview Table 175. Response Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 176. Response Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 177. Response Biomedical Recent Development Table 178. Princeton BioMeditech Company Information Table 179. Princeton BioMeditech Business Overview Table 180. Princeton BioMeditech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 181. Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio Table 182. Princeton BioMeditech Recent Development Table 183. Alfa Wassermann Company Information Table 184. Alfa Wassermann Business Overview Table 185. Alfa Wassermann Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 186. Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio Table 187. Alfa Wassermann Recent Development Table 188. North America Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 189. North America Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 190. North America Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 191. North America Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 192. North America Point-of-Care Testing (POCT) Sales Price by Type (2021-2026) & (USD/Unit) Table 193. North America Point-of-Care Testing (POCT) Sales Price by Type (2027-2032) & (USD/Unit) Table 194. North America Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 195. North America Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 196. North America Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 197. North America Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 198. North America Point-of-Care Testing (POCT) Sales Price by Application (2021-2026) & (USD/Unit) Table 199. North America Point-of-Care Testing (POCT) Sales Price by Application (2027-2032) & (USD/Unit) Table 200. North America Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. North America Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. North America Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. North America Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 204. North America Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 205. North America Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 206. North America Point-of-Care Testing (POCT) Sales Price by Country (2021-2026) & (USD/Unit) Table 207. North America Point-of-Care Testing (POCT) Sales Price by Country (2027-2032) & (USD/Unit) Table 208. United States Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 209. Canada Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 210. Mexico Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 211. Europe Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 212. Europe Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 213. Europe Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 214. Europe Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 215. Europe Point-of-Care Testing (POCT) Sales Price by Type (2021-2026) & (USD/Unit) Table 216. Europe Point-of-Care Testing (POCT) Sales Price by Type (2027-2032) & (USD/Unit) Table 217. Europe Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 218. Europe Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 219. Europe Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 220. Europe Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 221. Europe Point-of-Care Testing (POCT) Sales Price by Application (2021-2026) & (USD/Unit) Table 222. Europe Point-of-Care Testing (POCT) Sales Price by Application (2027-2032) & (USD/Unit) Table 223. Europe Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 224. Europe Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 225. Europe Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 226. Europe Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 227. Europe Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 228. Europe Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 229. Europe Point-of-Care Testing (POCT) Sales Price by Country (2021-2026) & (USD/Unit) Table 230. Europe Point-of-Care Testing (POCT) Sales Price by Country (2027-2032) & (USD/Unit) Table 231. Germany Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 232. France Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 233. U.K. Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 234. Italy Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 235. Russia Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 236. Spain Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 237. Netherlands Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 238. Switzerland Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 239. Sweden Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 240. Poland Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 241. China Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 242. China Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 243. China Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 244. China Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 245. China Point-of-Care Testing (POCT) Sales Price by Type (2021-2026) & (USD/Unit) Table 246. China Point-of-Care Testing (POCT) Sales Price by Type (2027-2032) & (USD/Unit) Table 247. China Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 248. China Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 249. China Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 250. China Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 251. China Point-of-Care Testing (POCT) Sales Price by Application (2021-2026) & (USD/Unit) Table 252. China Point-of-Care Testing (POCT) Sales Price by Application (2027-2032) & (USD/Unit) Table 253. Asia Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 254. Asia Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 255. Asia Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 256. Asia Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 257. Asia Point-of-Care Testing (POCT) Sales Price by Type (2021-2026) & (USD/Unit) Table 258. Asia Point-of-Care Testing (POCT) Sales Price by Type (2027-2032) & (USD/Unit) Table 259. Asia Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 260. Asia Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 261. Asia Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 262. Asia Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 263. Asia Point-of-Care Testing (POCT) Sales Price by Application (2021-2026) & (USD/Unit) Table 264. Asia Point-of-Care Testing (POCT) Sales Price by Application (2027-2032) & (USD/Unit) Table 265. Asia Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. Asia Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 267. Asia Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 268. Asia Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 269. Asia Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 270. Asia Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 271. Asia Point-of-Care Testing (POCT) Sales Price by Country (2021-2026) & (USD/Unit) Table 272. Asia Point-of-Care Testing (POCT) Sales Price by Country (2027-2032) & (USD/Unit) Table 273. Japan Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 274. South Korea Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 275. India Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 276. Australia Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 277. Taiwan Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 278. Southeast Asia Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 279. SAMEA Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 280. SAMEA Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 281. SAMEA Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 282. SAMEA Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 283. SAMEA Point-of-Care Testing (POCT) Sales Price by Type (2021-2026) & (USD/Unit) Table 284. SAMEA Point-of-Care Testing (POCT) Sales Price by Type (2027-2032) & (USD/Unit) Table 285. SAMEA Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 286. SAMEA Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 287. SAMEA Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 288. SAMEA Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 289. SAMEA Point-of-Care Testing (POCT) Sales Price by Application (2021-2026) & (USD/Unit) Table 290. SAMEA Point-of-Care Testing (POCT) Sales Price by Application (2027-2032) & (USD/Unit) Table 291. SAMEA Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 292. SAMEA Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 293. SAMEA Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 294. SAMEA Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 295. SAMEA Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 296. SAMEA Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 297. SAMEA Point-of-Care Testing (POCT) Sales Price by Country (2021-2026) & (USD/Unit) Table 298. SAMEA Point-of-Care Testing (POCT) Sales Price by Country (2027-2032) & (USD/Unit) Table 299. Brazil Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 300. Argentina Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 301. Chile Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 302. Colombia Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 303. Peru Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 304. Saudi Arabia Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 305. Israel Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 306. UAE Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 307. Turkey Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 308. Iran Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 309. Egypt Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Table 310. Key Raw Materials Table 311. Raw Materials Key Suppliers Table 312. Point-of-Care Testing (POCT) Distributors List Table 313. Point-of-Care Testing (POCT) Customers List Table 314. Research Programs/Design for This Report Table 315. Authors List of This Report Table 316. Secondary Sources Table 317. Primary Sources List of Figures Figure 1. Point-of-Care Testing (POCT) Image Figure 2. Global Point-of-Care Testing (POCT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Point-of-Care Testing (POCT) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Glucose Testing Image Figure 5. Infectious Diseases Testing Image Figure 6. Cardiac Markers Testing Image Figure 7. Coagulation Testing Image Figure 8. Pregnancy and Fertility Testing Image Figure 9. Blood Gas/Electrolytes Testing Image Figure 10. Urinalysis Testing Image Figure 11. Global Point-of-Care Testing (POCT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Point-of-Care Testing (POCT) Market Size Share 2021 VS 2025 VS 2032 Figure 13. Clinics Image Figure 14. Hospitals Image Figure 15. Laboratory Image Figure 16. Others Image Figure 17. Global Point-of-Care Testing (POCT) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Figure 19. Global Point-of-Care Testing (POCT) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Point-of-Care Testing (POCT) Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2021-2032) Figure 22. Global Point-of-Care Testing (POCT) Sales (2021-2032) & (M Units) Figure 23. Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 24. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Point-of-Care Testing (POCT) Sales YoY (2021-2032) & (M Units) Figure 26. Europe Point-of-Care Testing (POCT) Sales YoY (2021-2032) & (M Units) Figure 27. China Point-of-Care Testing (POCT) Sales YoY (2021-2032) & (M Units) Figure 28. Asia (Excluding China) Point-of-Care Testing (POCT) Sales YoY (2021-2032) & (M Units) Figure 29. South America, Middle East and Africa Point-of-Care Testing (POCT) Sales YoY (2021-2032) & (M Units) Figure 30. Global Point-of-Care Testing (POCT) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Point-of-Care Testing (POCT) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Point-of-Care Testing (POCT) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Point-of-Care Testing (POCT) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2032) Figure 36. Global Point-of-Care Testing (POCT) Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 37. Global Point-of-Care Testing (POCT) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2032) Figure 39. Global Point-of-Care Testing (POCT) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Point-of-Care Testing (POCT) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2032) Figure 42. Global Point-of-Care Testing (POCT) Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 43. Global Point-of-Care Testing (POCT) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2032) Figure 45. North America Point-of-Care Testing (POCT) Revenue Share by Type (2021-2032) Figure 46. North America Point-of-Care Testing (POCT) Sales Share by Type (2021-2032) Figure 47. North America Point-of-Care Testing (POCT) Revenue Share by Application (2021-2032) Figure 48. North America Point-of-Care Testing (POCT) Sales Share by Application (2021-2032) Figure 49. North America Point-of-Care Testing (POCT) Revenue Share by Country (2021-2032) Figure 50. North America Point-of-Care Testing (POCT) Sales Share by Country (2021-2032) Figure 51. Europe Point-of-Care Testing (POCT) Revenue Share by Type (2021-2032) Figure 52. Europe Point-of-Care Testing (POCT) Sales Share by Type (2021-2032) Figure 53. Europe Point-of-Care Testing (POCT) Revenue Share by Application (2021-2032) Figure 54. Europe Point-of-Care Testing (POCT) Sales Share by Application (2021-2032) Figure 55. Europe Point-of-Care Testing (POCT) Revenue Share by Country (2021-2032) Figure 56. Europe Point-of-Care Testing (POCT) Sales Share by Country (2021-2032) Figure 57. China Point-of-Care Testing (POCT) Revenue Share by Type (2021-2032) Figure 58. China Point-of-Care Testing (POCT) Sales Share by Type (2021-2032) Figure 59. China Point-of-Care Testing (POCT) Revenue Share by Application (2021-2032) Figure 60. China Point-of-Care Testing (POCT) Sales Share by Application (2021-2032) Figure 61. Asia Point-of-Care Testing (POCT) Revenue Share by Type (2021-2032) Figure 62. Asia Point-of-Care Testing (POCT) Sales Share by Type (2021-2032) Figure 63. Asia Point-of-Care Testing (POCT) Revenue Share by Application (2021-2032) Figure 64. Asia Point-of-Care Testing (POCT) Sales Share by Application (2021-2032) Figure 65. Asia Point-of-Care Testing (POCT) Revenue Share by Country (2021-2032) Figure 66. Asia Point-

Scope & coverage.

Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Companies covered
  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Trinity Biotech
  • ELITech Group
  • Response Biomedical
  • Princeton BioMeditech
  • Alfa Wassermann

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Point-of-Care Testing (POCT) Market by Type
  3. 1.2.1 Global Point-of-Care Testing (POCT) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Glucose Testing
  5. 1.2.3 Infectious Diseases Testing
  6. 1.2.4 Cardiac Markers Testing
  7. 1.2.5 Coagulation Testing
  8. 1.2.6 Pregnancy and Fertility Testing
  9. 1.2.7 Blood Gas/Electrolytes Testing
  10. 1.2.8 Urinalysis Testing
  11. 1.3 Point-of-Care Testing (POCT) Market by Application
  12. 1.3.1 Global Point-of-Care Testing (POCT) Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Clinics
  14. 1.3.3 Hospitals
  15. 1.3.4 Laboratory
  16. 1.3.5 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Point-of-Care Testing (POCT) Market Dynamics
  1. 2.1 Point-of-Care Testing (POCT) Industry Trends
  2. 2.2 Point-of-Care Testing (POCT) Industry Drivers
  3. 2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
  4. 2.4 Point-of-Care Testing (POCT) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Point-of-Care Testing (POCT) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Point-of-Care Testing (POCT) Revenue by Region
  3. 3.2.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Point-of-Care Testing (POCT) Revenue by Region (2021-2026)
  5. 3.2.3 Global Point-of-Care Testing (POCT) Revenue by Region (2027-2032)
  6. 3.2.4 Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Point-of-Care Testing (POCT) Sales by Region
  9. 3.4.1 Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Point-of-Care Testing (POCT) Sales by Region (2021-2026)
  11. 3.4.3 Global Point-of-Care Testing (POCT) Sales by Region (2027-2032)
  12. 3.4.4 Global Point-of-Care Testing (POCT) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers
  2. 4.1.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Point-of-Care Testing (POCT) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Point-of-Care Testing (POCT) Sales by Manufacturers
  6. 4.2.1 Global Point-of-Care Testing (POCT) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Point-of-Care Testing (POCT) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Point-of-Care Testing (POCT) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Point-of-Care Testing (POCT) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application
  13. 4.7 Global Point-of-Care Testing (POCT) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
  16. 4.8.2 2025 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier 3
5 Point-of-Care Testing (POCT) Market by Type
  1. 5.1 Global Point-of-Care Testing (POCT) Revenue by Type
  2. 5.1.1 Global Point-of-Care Testing (POCT) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Point-of-Care Testing (POCT) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Point-of-Care Testing (POCT) Sales by Type
  6. 5.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Point-of-Care Testing (POCT) Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Point-of-Care Testing (POCT) Price by Type
6 Point-of-Care Testing (POCT) Market by Application
  1. 6.1 Global Point-of-Care Testing (POCT) Revenue by Application
  2. 6.1.1 Global Point-of-Care Testing (POCT) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Point-of-Care Testing (POCT) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Point-of-Care Testing (POCT) Sales by Application
  6. 6.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Point-of-Care Testing (POCT) Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Point-of-Care Testing (POCT) Price by Application
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Abbott
  8. 7.2.1 Abbott Company Information
  9. 7.2.2 Abbott Business Overview
  10. 7.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
  12. 7.2.5 Abbott Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Siemens Healthcare
  20. 7.4.1 Siemens Healthcare Company Information
  21. 7.4.2 Siemens Healthcare Business Overview
  22. 7.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
  24. 7.4.5 Siemens Healthcare Recent Developments
  25. 7.5 Danaher
  26. 7.5.1 Danaher Company Information
  27. 7.5.2 Danaher Business Overview
  28. 7.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
  30. 7.5.5 Danaher Recent Developments
  31. 7.6 Ascensia
  32. 7.6.1 Ascensia Company Information
  33. 7.6.2 Ascensia Business Overview
  34. 7.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
  36. 7.6.5 Ascensia Recent Developments
  37. 7.7 Bio-Rad Laboratories
  38. 7.7.1 Bio-Rad Laboratories Company Information
  39. 7.7.2 Bio-Rad Laboratories Business Overview
  40. 7.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
  42. 7.7.5 Bio-Rad Laboratories Recent Developments
  43. 7.8 BioMerieux
  44. 7.8.1 BioMerieux Company Information
  45. 7.8.2 BioMerieux Business Overview
  46. 7.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
  48. 7.8.5 BioMerieux Recent Developments
  49. 7.9 ARKRAY
  50. 7.9.1 ARKRAY Company Information
  51. 7.9.2 ARKRAY Business Overview
  52. 7.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
  54. 7.9.5 ARKRAY Recent Developments
  55. 7.10 Nova Biomedical
  56. 7.10.1 Nova Biomedical Company Information
  57. 7.10.2 Nova Biomedical Business Overview
  58. 7.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
  60. 7.10.5 Nova Biomedical Recent Developments
  61. 7.11 Trividia Health
  62. 7.11.1 Trividia Health Company Information
  63. 7.11.2 Trividia Health Business Overview
  64. 7.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
  66. 7.11.5 Trividia Health Recent Developments
  67. 7.12 Quidel
  68. 7.12.1 Quidel Company Information
  69. 7.12.2 Quidel Business Overview
  70. 7.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
  72. 7.12.5 Quidel Recent Developments
  73. 7.13 Accriva
  74. 7.13.1 Accriva Company Information
  75. 7.13.2 Accriva Business Overview
  76. 7.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
  78. 7.13.5 Accriva Recent Developments
  79. 7.14 OraSure Technologies
  80. 7.14.1 OraSure Technologies Company Information
  81. 7.14.2 OraSure Technologies Business Overview
  82. 7.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
  84. 7.14.5 OraSure Technologies Recent Developments
  85. 7.15 Helena Laboratories
  86. 7.15.1 Helena Laboratories Company Information
  87. 7.15.2 Helena Laboratories Business Overview
  88. 7.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
  90. 7.15.5 Helena Laboratories Recent Developments
  91. 7.16 A. Menarini Diagnostics
  92. 7.16.1 A. Menarini Diagnostics Company Information
  93. 7.16.2 A. Menarini Diagnostics Business Overview
  94. 7.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  96. 7.16.5 A. Menarini Diagnostics Recent Developments
  97. 7.17 Abaxis (Zoetis)
  98. 7.17.1 Abaxis (Zoetis) Company Information
  99. 7.17.2 Abaxis (Zoetis) Business Overview
  100. 7.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
  102. 7.17.5 Abaxis (Zoetis) Recent Developments
  103. 7.18 Ortho Clinical Diagnostics
  104. 7.18.1 Ortho Clinical Diagnostics Company Information
  105. 7.18.2 Ortho Clinical Diagnostics Business Overview
  106. 7.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  108. 7.18.5 Ortho Clinical Diagnostics Recent Developments
  109. 7.19 Phamatech
  110. 7.19.1 Phamatech Company Information
  111. 7.19.2 Phamatech Business Overview
  112. 7.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
  114. 7.19.5 Phamatech Recent Developments
  115. 7.20 Chembio Diagnostics
  116. 7.20.1 Chembio Diagnostics Company Information
  117. 7.20.2 Chembio Diagnostics Business Overview
  118. 7.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  120. 7.20.5 Chembio Diagnostics Recent Developments
  121. 7.21 Trinity Biotech
  122. 7.21.1 Trinity Biotech Company Information
  123. 7.21.2 Trinity Biotech Business Overview
  124. 7.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
  126. 7.21.5 Trinity Biotech Recent Developments
  127. 7.22 ELITech Group
  128. 7.22.1 ELITech Group Company Information
  129. 7.22.2 ELITech Group Business Overview
  130. 7.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
  132. 7.22.5 ELITech Group Recent Developments
  133. 7.23 Response Biomedical
  134. 7.23.1 Response Biomedical Company Information
  135. 7.23.2 Response Biomedical Business Overview
  136. 7.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
  138. 7.23.5 Response Biomedical Recent Developments
  139. 7.24 Princeton BioMeditech
  140. 7.24.1 Princeton BioMeditech Company Information
  141. 7.24.2 Princeton BioMeditech Business Overview
  142. 7.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
  144. 7.24.5 Princeton BioMeditech Recent Developments
  145. 7.25 Alfa Wassermann
  146. 7.25.1 Alfa Wassermann Company Information
  147. 7.25.2 Alfa Wassermann Business Overview
  148. 7.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
  150. 7.25.5 Alfa Wassermann Recent Developments
8 North America
  1. 8.1 North America Point-of-Care Testing (POCT) Market Size by Type
  2. 8.1.1 North America Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  3. 8.1.2 North America Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  4. 8.1.3 North America Point-of-Care Testing (POCT) Price by Type (2021-2032)
  5. 8.2 North America Point-of-Care Testing (POCT) Market Size by Application
  6. 8.2.1 North America Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  7. 8.2.2 North America Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  8. 8.2.3 North America Point-of-Care Testing (POCT) Price by Application (2021-2032)
  9. 8.3 North America Point-of-Care Testing (POCT) Market Size by Country
  10. 8.3.1 North America Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Point-of-Care Testing (POCT) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Point-of-Care Testing (POCT) Market Size by Type
  2. 9.1.1 Europe Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  4. 9.1.3 Europe Point-of-Care Testing (POCT) Price by Type (2021-2032)
  5. 9.2 Europe Point-of-Care Testing (POCT) Market Size by Application
  6. 9.2.1 Europe Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  8. 9.2.3 Europe Point-of-Care Testing (POCT) Price by Application (2021-2032)
  9. 9.3 Europe Point-of-Care Testing (POCT) Market Size by Country
  10. 9.3.1 Europe Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Point-of-Care Testing (POCT) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Point-of-Care Testing (POCT) Market Size by Type
  2. 10.1.1 China Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  3. 10.1.2 China Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  4. 10.1.3 China Point-of-Care Testing (POCT) Price by Type (2021-2032)
  5. 10.2 China Point-of-Care Testing (POCT) Market Size by Application
  6. 10.2.1 China Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  7. 10.2.2 China Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  8. 10.2.3 China Point-of-Care Testing (POCT) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Point-of-Care Testing (POCT) Market Size by Type
  2. 11.1.1 Asia Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  4. 11.1.3 Asia Point-of-Care Testing (POCT) Price by Type (2021-2032)
  5. 11.2 Asia Point-of-Care Testing (POCT) Market Size by Application
  6. 11.2.1 Asia Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  8. 11.2.3 Asia Point-of-Care Testing (POCT) Price by Application (2021-2032)
  9. 11.3 Asia Point-of-Care Testing (POCT) Market Size by Country
  10. 11.3.1 Asia Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Point-of-Care Testing (POCT) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Point-of-Care Testing (POCT) Market Size by Type
  2. 12.1.1 SAMEA Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Point-of-Care Testing (POCT) Price by Type (2021-2032)
  5. 12.2 SAMEA Point-of-Care Testing (POCT) Market Size by Application
  6. 12.2.1 SAMEA Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Point-of-Care Testing (POCT) Price by Application (2021-2032)
  9. 12.3 SAMEA Point-of-Care Testing (POCT) Market Size by Country
  10. 12.3.1 SAMEA Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Point-of-Care Testing (POCT) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Point-of-Care Testing (POCT) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Point-of-Care Testing (POCT) Value Chain Analysis
  2. 13.1.1 Point-of-Care Testing (POCT) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Point-of-Care Testing (POCT) Production Mode & Process
  6. 13.2 Point-of-Care Testing (POCT) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Point-of-Care Testing (POCT) Distributors
  9. 13.2.3 Point-of-Care Testing (POCT) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst